Acquired generalized lipodystrophy
ORPHA:79086DiseaseNot applicableAll ages
Фенотипы (HPO)28
Облигатный (100%)1
HP:0009064Generalized lipodystrophy
Очень частый (80–99%)2
HP:0000842Hyperinsulinemia
HP:0000855Insulin resistance
Частый (30–79%)8
HP:0000831Insulin-resistant diabetes mellitus
HP:0001397Hepatic steatosis
HP:0001638Cardiomyopathy
HP:0002960Autoimmunity
HP:0003119Abnormal circulating lipid concentration
HP:0003707Calf muscle pseudohypertrophy
HP:0005328Progeroid facial appearance
HP:0011025Abnormality of cardiovascular system physiology
Периодический (5–29%)14
HP:0000093Proteinuria
HP:0000147Polycystic ovaries
HP:0000822Hypertension
HP:0000956Acanthosis nigricans
HP:0001394Cirrhosis
HP:0001735Acute pancreatitis
HP:0002155Hypertriglyceridemia
HP:0002230Generalized hirsutism
HP:0002240Hepatomegaly
HP:0003198Myopathy
HP:0005339Abnormality of complement system
HP:0005616Accelerated skeletal maturation
HP:0007440Generalized hyperpigmentation
HP:0012490Panniculitis
Очень редкий (1–4%)3
HP:0002665Lymphoma
HP:0009592Astrocytoma
HP:0012064Unicameral bone cyst
Эпидемиология2
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | Unknown | — | Worldwide | Class only |
| Point prevalence | 1-9 / 100 000 | 1 | Europe | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)